Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer von Shaw, Alice T, Ou, Sai-Hong I, Bang, Yung-Jue, Camidge, D. Ross, Solomon, Benjamin J, Salgia, Ravi, Riely, Gregory J, Varella-Garcia, Marileila, Shapiro, Geoffrey I, Costa, Daniel B, Doebele, Robert C, Le, Long Phi, Zheng, Zongli, Tan, Weiwei, Stephenson, Patricia, Shreeve, S. Martin, Tye, Lesley M, Christensen, James G, Wilner, Keith D, Clark, Jeffrey W, Iafrate, A. John

Volltext

Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer von Solomon, B, Wilner, KD, Shaw, AT

Volltext

A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP-101,606 in Patients with a Mild or Moderate Traumatic Brain Injury von MERCHANT, RANDALL E., BULLOCK, M. ROSS, CARMACK, CYNTHIA A., SHAH, AJIT K., WILNER, KEITH D., KO, GRANT, WILLIAMS, STEPHEN A.

Volltext

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucas... von Myrand, SP, Sekiguchi, K, Man, MZ, Lin, X, Tzeng, R‐Y, Teng, C‐H, Hee, B, Garrett, M, Kikkawa, H, Lin, C‐Y, Eddy, SM, Dostalik, J, Mount, J, Azuma, J, Fujio, Y, Jang, I‐J, Shin, S‐G, Bleavins, MR, Williams, JA, Paulauskis, JD, Wilner, KD

Volltext

Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the Un... von Ehrenstein, Vera, Huang, Kui, Kahlert, Johnny, Bahmanyar, Shahram, Karlsson, Pär, Löfling, Lukas, Nunes, Anthony P., Enger, Cheryl, Bezemer, Irene D., Kuiper, Josephina G., Hoti, Fabian, Juuti, Rosa, Korhonen, Pasi, Mo, Jingping, Schachterle, Stephen E., Wilner, Keith D., Rørth, Mikael, Sørensen, Henrik T.

Volltext

An Open-Label Study of CP-101,606 in Subjects with a Severe Traumatic Head Injury or Spontaneous Intracerebral Hemorrhage von BULLOCK, M. ROSS, MERCHANT, RANDALL E., CARMACK, CYNTHIA A., DOPPENBERG, EGON, SHAH, AJIT K., WILNER, KEITH D., KO, GRANT, WILLIAMS, STEPHEN A.

Volltext

Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib von Selaru, P, Tang, Y, Huang, B, Polli, A, Wilner, KD, Donnelly, E, Cohen, DP

Volltext

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder von GOFF, D. C, POSEVER, T, HERZ, L, SIMMONS, J, KLETTI, N, LAPIERRE, K, WILNER, K. D, LAW, C. G, KO, G. N

Volltext

Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers von Wilner, Keith D, Rushing, Margaret, Walden, Catherine, Adler, Rebecca, Eskra, James, Noveck, Robert, Vargas, Ramon

Volltext

Single‐ and multiple‐dose pharmacokinetics of ziprasidone under non‐fasting conditions in healthy male volunteers von Miceli, J. J., Wilner, K. D., Hansen, R. A., Johnson, A. C., Apseloff, G., Gerber, N.

Volltext

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers von Ronfeld, R A, Tremaine, L M, Wilner, K D

Volltext

Pharmacokinetics, Safety, and Tolerability of Intramuscular Ziprasidone in Healthy Volunteers von Miceli, Jeffrey J., Wilner, Keith D., Swan, Suzanne K., Tensfeldt, Thomas G.

Volltext

Single‐ and multiple‐dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers von Wilner, K. D., Tensfeldt, T. G., Baris, B., Smolarek, T. A., Turncliff, R. Z., Colburn, W. A., Hansen, R. A.

Volltext

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function von Aweeka, F., Jayesekara, D., Horton, M., Swan, S., Lambrecht, L., Wilner, K. D., Sherwood, J., Anziano, R. J., Smolarek, T. A., Turncliff, R. Z.

Volltext

The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery von WILNER, Keith D, ANZIANO, Richard J, JOHNSON, Arlene C, MICELI, Jeffrey J, FRICKE, James R, TITUS, Cynthia K

Volltext

The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid von Wilner, K. D., Hansen, R. A., Folger, C. J., Geoffroy, P.

Volltext

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers von Wilner, K. D., Demattos, S. B., Anziano, R. J., Apseloff, G., Gerber, N.

Volltext

The effects of ziprasidone on steady‐state lithium levels and renal clearance of lithium von Apseloff, G., Mullet, D., Wilner, K. D., Anziano, R. J., Tensfeldt, T. G., Pelletier, S. M., Gerber, N.

Volltext

The Effect of Timing of a Standard Meal on the Pharmacokinetics and Pharmacodynamics of the Novel Atypical Antipsychotic Agent Ziprasidone von Hamelin, Bettina A., Allard, Sylvie, Laplante, Louis, Miceli, Jeffrey, Wilner, Keith D., Tremblay, J., LeBel, Marc

Volltext

Effect of sertraline on protein binding of warfarin von Apseloff, G, Wilner, K D, Gerber, N, Tremaine, L M

Volltext